| Scrip Code | 533179 |
|---|---|
| NSE Symbol | PERSISTENT |
| MSEI Symbol | NOTLISTED |
| ISIN | INE262H01021 |
| Name of company | Persistent Systems Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 21-04-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 31-03-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Fourth quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 21-04-2026 09:15:00 |
| End date and time of board meeting | 21-04-2026 15:20:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 4,05,593.70 | 14,74,844.90 | |
| Other income | 3,349.20 | 18,042.60 | |
| Total income | 4,08,942.90 | 14,92,887.50 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 |
| (d) | Employee benefit expense | 2,75,826.70 | 10,14,815.60 |
| (e) | Finance costs | 1,867.50 | 7,268.20 |
| (f) | Depreciation, depletion and amortisation expense | 10,853.90 | 40,295.00 |
| (f) | Other Expenses | ||
| 1 | Purchase of software licenses | 31,304.10 | 1,00,803.90 |
| 2 | Legal and professional fees | 5,849.40 | 20,327.80 |
| 3 | Travelling and conveyance | 6,200.40 | 22,994.30 |
| 4 | Miscellaneous expenses | 2,348.10 | 7,725.60 |
| 5 | Recruitment expenses | 698.40 | 3,061.70 |
| 6 | Advertisement, conference and sponsorship fees | 551.00 | 2,034.50 |
| 7 | Rent | 550.10 | 1,366.70 |
| 8 | Allowance for expected credit loss (net) | 260.70 | 2,852.70 |
| 9 | Training and seminars | 657.00 | 1,968.20 |
| 10 | Other Expenses | 4,577.50 | 17,349.60 |
| Total other expenses | 52,996.70 | 1,80,485.00 | |
| Total expenses | 3,41,544.80 | 12,42,863.80 | |
| 3 | Total profit before exceptional items and tax | 67,398.10 | 2,50,023.70 |
| 4 | Exceptional items | 0.00 | (8,902.50) |
| 5 | Total profit before tax | 67,398.10 | 2,41,121.20 |
| 6 | Tax expense | ||
| 7 | Current tax | 15,119.30 | 59,724.50 |
| 8 | Deferred tax | (647.20) | (5,115.30) |
| 9 | Total tax expenses | 14,472.10 | 54,609.20 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 52,926.00 | 1,86,512.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 52,926.00 | 1,86,512.00 |
| 17 | Other comprehensive income net of taxes | (2,482.10) | 1,517.20 |
| 18 | Total Comprehensive Income for the period | 50,443.90 | 1,88,029.20 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 52,926.00 | 1,86,512.00 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 50,443.90 | 1,88,029.20 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 7,887.50 | 7,887.50 | |
| Face value of equity share capital | 5 | 5 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 0.00 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 33.83 | 119.74 | |
| Diluted earnings (loss) per share from continuing operations | 33.55 | 118.87 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 33.83 | 119.74 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 33.55 | 118.87 | |
| 24 | Debt equity ratio | 0 | 0 |
| 25 | Debt service coverage ratio | 0 | 0 |
| 26 | Interest service coverage ratio | 0 | 0 |
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Due to character limitation in filling the notes in this tab, please refer to our submission under Ref. No. NSE & BSE / 2026-27 / 006 dated April 21, 2026, which covers the financial results under Regulation 33 of the SEBI (LODR) Regulations, 2015 including notes thereto. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2025 | |
| Date of end of reporting period | 31-03-2026 | |
| Whether results are audited or unaudited | Audited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 39,688.80 | |
| Capital work-in-progress | 1,068.50 | |
| Investment property | 54,718.10 | |
| Goodwill | 1,35,968.80 | |
| Other intangible assets | 55,222.50 | |
| Intangible assets under development | 2,689.50 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 0.00 | |
| Non-current financial assets | ||
| Non-current investments | 70,013.80 | |
| Trade receivables, non-current | 8,993.60 | |
| Loans, non-current | 0.00 | |
| Other non-current financial assets | ||
| 1 | Other Financial Assets | 10,129.90 |
| Total of other non-current financial assets | 10,129.90 | |
| Total non-current financial assets | 89,137.30 | |
| Deferred tax assets (net) | 34,599.70 | |
| Other non-current assets | ||
| 1 | Other non-current assets | 4,503.20 |
| 2 | Income Tax Assets | 10,329.70 |
| Total of other non-current assets | 14,832.90 | |
| Total non-current assets | 4,27,926.10 | |
| 2 | Current assets | |
| Inventories | 0.00 | |
| Current financial asset | ||
| Current investments | 91,462.80 | |
| Trade receivables, current | 3,33,438.70 | |
| Cash and cash equivalents | 1,07,491.50 | |
| Bank balance other than cash and cash equivalents | 14,333.60 | |
| Loans, current | 0.00 | |
| Other current financial assets | ||
| Total of other current financial assets | 734.50 | |
| Total current financial assets | 5,47,461.10 | |
| Current tax assets (net) | 0.00 | |
| Other current assets | ||
| 1 | Other current assets | 1,62,267.20 |
| Total of other current assets | 1,62,267.20 | |
| Total current assets | 7,09,728.30 | |
| 3 | Non-current assets classified as held for sale | 0.00 |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 |
| Total assets | 11,37,654.40 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 7,887.50 | |
| Other equity | 7,75,898.00 | |
| Total equity attributable to owners of parent | 7,83,785.50 | |
| Non controlling interest | 0.00 | |
| Total equity | 7,83,785.50 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 0.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | |
| Total Trade payable | 0.00 | |
| Other non-current financial liabilities | ||
| 1 | Lease Liabilities | 29,967.00 |
| 2 | Other Financial Liabilities | 1,571.40 |
| Total of other non-current financial liabilities | 31,538.40 | |
| Total non-current financial liabilities | 31,538.40 | |
| Provisions, non-current | 26,327.70 | |
| Deferred tax liabilities (net) | 3,262.80 | |
| Deferred government grants, Non-current | 0.00 | |
| Other non-current liabilities | ||
| 1 | Other non-current liabilities | 314.40 |
| Total of other non-current liabilities | 314.40 | |
| Total non-current liabilities | 61,443.30 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 0.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 581.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 1,12,837.80 | |
| Total Trade payable | 1,13,418.80 | |
| Other current financial liabilities | ||
| 1 | Other Financial Liabilities | 82,726.90 |
| 2 | Lease Liabilities | 17,777.80 |
| Total of other current financial liabilities | 1,00,504.70 | |
| Total current financial liabilities | 2,13,923.50 | |
| Other current liabilities | 68,053.60 | |
| 1 | Other current liabilities | 68,053.60 |
| Total of other current liabilities | 68,053.60 | |
| Provisions, current | 5,702.50 | |
| Current tax liabilities (Net) | 4,746.00 | |
| Deferred government grants, Current | 0.00 | |
| Total current liabilities | 2,92,425.60 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 |
| Total liabilities | 3,53,868.90 | |
| Total equity and liabilites | 11,37,654.40 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | |||||
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | |||||
| Whether results are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | BFSI | 1,39,627.80 | 5,09,329.90 | ||||
| 2 | Healthcare & Life Sciences | 1,06,627.60 | 3,77,216.50 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 1,59,338.30 | 5,88,298.50 | ||||
| Total Segment Revenue | 4,05,593.70 | 14,74,844.90 | |||||
| Less: Inter segment revenue | 0.00 | 0.00 | |||||
| Revenue from operations | 4,05,593.70 | 14,74,844.90 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | BFSI | 49,690.70 | 1,76,859.20 | ||||
| 2 | Healthcare & Life Sciences | 39,958.70 | 1,40,295.80 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 54,905.00 | 2,05,926.70 | ||||
| Total Profit before tax | 1,44,554.40 | 5,23,081.70 | |||||
| i. Finance cost | 1,867.50 | 7,268.20 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 75,288.80 | 2,74,692.30 | |||||
| Profit before tax | 67,398.10 | 2,41,121.20 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | BFSI | 67,426.80 | 67,426.80 | ||||
| 2 | Healthcare & Life Sciences | 77,770.50 | 77,770.50 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 2,17,160.10 | 2,17,160.10 | ||||
| Total Segment Asset | 3,62,357.40 | 3,62,357.40 | |||||
| Un-allocable Assets | 7,75,297.00 | 7,75,297.00 | |||||
| Net Segment Asset | 11,37,654.40 | 11,37,654.40 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | BFSI | 0.00 | 0.00 | ||||
| 2 | Healthcare & Life Sciences | 0.00 | 0.00 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 0.00 | 0.00 | ||||
| Total Segment Liabilities | 0.00 | 0.00 | |||||
| Un-allocable Liabilities | 3,53,868.90 | 3,53,868.90 | |||||
| Net Segment Liabilities | 3,53,868.90 | 3,53,868.90 | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurements of the defined benefit liabilities / (asset) | 1,838.90 | 2,118.30 |
| Total Amount of items that will not be reclassified to profit and loss | 1,838.90 | 2,118.30 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 463.10 | 533.40 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Effective portion of cash flow hedge | (13,965.00) | (22,366.00) |
| 2 | Exchange differences in translating the financial statements of foreign operations | 6,592.40 | 16,669.20 |
| Total Amount of items that will be reclassified to profit and loss | (7,372.60) | (5,696.80) | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | (3,514.70) | (5,629.10) |
| 5 | Total Other comprehensive income | (2,482.10) | 1,517.20 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 31-03-2026 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 2,41,121.20 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 7,268.20 | |||||
| Adjustments for decrease (increase) in inventories | 0.00 | |||||
| Adjustments for decrease (increase) in trade receivables, current | 1,544.80 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (60,386.60) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | (1,987.60) | |||||
| Adjustments for other financial assets, current | 0.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | (11,765.80) | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 0.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 40,295.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 4,745.40 | |||||
| Adjustments for provisions, current | 16,070.00 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | (1,356.30) | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | 1,396.80 | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 5,018.70 | |||||
| Adjustments for share-based payments | 15,777.90 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | (7,104.10) | |||||
| Other adjustments for non-cash items | (1,395.90) | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | (1,916.90) | |||||
| Net cash flows from (used in) operations | 2,39,204.30 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 62,491.30 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 1,76,713.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | (20,858.10) | |||||
| Purchase of property, plant and equipment | (1,339.70) | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 4,980.30 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (46,452.20) | |||||
| Net cash flows from (used in) investing activities | (60,990.30) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 20,485.70 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 25,477.70 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 0.00 | |||||
| Repayments of borrowings | 0.00 | |||||
| Payments of lease liabilities | 17,976.80 | |||||
| Dividends paid | 57,904.10 | |||||
| Interest paid | 3,928.70 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (74,817.60) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 40,905.10 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | (854.20) | |||||
| Net increase (decrease) in cash and cash equivalents | 40,050.90 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 67,440.60 | |||||
| Cash and cash equivalents cash flow statement at end of period | 1,07,491.50 | |||||
| Whether results are audited or unaudited | Audited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | B S R & Co. LLP | Yes | 31-07-2028 | ||
|---|---|---|---|---|---|